A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task
This study, sponsored by Istanbul University, aims to enhance diagnostic capabilities in Alzheimer's Disease through a novel semantic recognition task. The focus on early-stage Alzheimer's patients may provide valuable insights into semantic processing deficits, potentially leading to improved clinical assessments and interventions. The market for Alzheimer's diagnostics is expanding, driven by increasing prevalence and demand for early detection methods. The findings could position Istanbul University as a key player in the Alzheimer's research landscape, attracting partnerships and funding opportunities. However, the absence of FDA regulation and the study's academic nature may limit immediate commercial applications.
Indication: Alzheimer Disease
Modality: behavioral intervention
Target: Semantic recognition processes related to temporal lobe activity in Alzheimer's Disease.
Sponsor: Istanbul University
Source URL: ClinicalTrials.gov
Source updated: Oct 02, 2024
Ingested: Jun 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Semantic recognition processes related to temporal lobe activity in Alzheimer's Disease.
View original source fields
Condition raw: Alzheimer Disease
Condition normalized: Alzheimer Disease
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Semantic recognition processes related to temporal lobe activity in Alzheimer's Disease.
Target normalized: Semantic recognition processes related to temporal lobe activity in Alzheimer's Disease.